CKD Bio Corp. (KRX:063160)

South Korea flag South Korea · Delayed Price · Currency is KRW
19,330
-970 (-4.78%)
Mar 4, 2026, 11:09 AM KST
-7.51%
Market Cap 111.36B
Revenue (ttm) 159.93B
Net Income (ttm) -23.13B
Shares Out 5.49M
EPS (ttm) -4,216.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 21,764
Average Volume 27,248
Open 20,250
Previous Close 20,300
Day's Range 19,310 - 20,250
52-Week Range 19,060 - 27,650
Beta 0.74
RSI 49.70
Earnings Date n/a

About CKD Bio

CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally. The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1941
Employees 519
Stock Exchange Korea Stock Exchange
Ticker Symbol 063160
Full Company Profile

Financial Performance

In 2022, CKD Bio's revenue was 156.04 billion, an increase of 9.70% compared to the previous year's 142.24 billion. Losses were -16.70 billion, 154.0% more than in 2021.

Financial Statements

News

There is no news available yet.